The Role of Apolipoprotein C-III in Coronary Artery Disease is organized by Baptist Health South Florida and would be held during May 01, 2017 - May 01, 2018.
Target Audience:
Cardiologists, Endocrinologists, Family Physicians, General Internists, Gynecologists, Internal Medicine Physicians, Physician Assistants and Fellows.This CME Conference has been approved for a maximum of 0.75 AMA PRA Category 1 Credit.
This lecture will address how apolipoprotein C-III has been referred to as an important participant in the metabolism of triglyceride-rich lipoproteins, leading to hypertriglyceridemia and thereafter cardiovascular disease. Learn more about innovative therapies for cardiovascular protection.
Learning Objectives:
• Examine the evidence indicating that apolipoprotein C-III can affect the development of cardiovascular disease.
• Explore the development of innovative therapies for cardiovascular protection.
Available Credit:
0.75 AMA PRA Category 1 Credit
0.75 General certificate of attendance
Additional details will be posted as soon as they are available.